These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36541594)

  • 1. Utility of Dark-Blood Dual-Energy CT Images for Predicting Vascular Involvement and R0 Resection in Patients With Pancreatic Cancer.
    Si K; Wu H; Yang M; Guo Y; Zhang X; Ding C; Xue J; Han P; Li X
    AJR Am J Roentgenol; 2023 Jun; 220(6):838-848. PubMed ID: 36541594
    [No Abstract]   [Full Text] [Related]  

  • 2. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
    Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
    Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual monochromatic image at lower energy level for assessing pancreatic ductal adenocarcinoma in fast kV-switching dual-energy CT.
    Noda Y; Goshima S; Kaga T; Ando T; Miyoshi T; Kawai N; Kawada H; Tanahashi Y; Matsuo M
    Clin Radiol; 2020 Apr; 75(4):320.e17-320.e23. PubMed ID: 31879024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
    Jang JK; Byun JH; Kang JH; Son JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Kim SC; Lee MG
    Eur Radiol; 2021 Feb; 31(2):813-823. PubMed ID: 32845389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
    Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
    Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma.
    Nagayama Y; Tanoue S; Inoue T; Oda S; Nakaura T; Utsunomiya D; Yamashita Y
    Eur Radiol; 2020 Jan; 30(1):394-403. PubMed ID: 31312889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of margin-negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT-determined resectability.
    Jang JK; Choi SJ; Byun JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Hwang DW; Kim SC
    J Hepatobiliary Pancreat Sci; 2022 Sep; 29(9):1025-1034. PubMed ID: 35658103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: comparison with pancreatic protocol CT.
    Noda Y; Kawai N; Kaga T; Ishihara T; Hyodo F; Kato H; Kambadakone AR; Matsuo M
    Abdom Radiol (NY); 2022 Aug; 47(8):2835-2844. PubMed ID: 35760922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical-radiomics nomogram based on dual-layer spectral detector CT to predict cancer stage in pancreatic ductal adenocarcinoma.
    Wu L; Cen C; Yue X; Chen L; Wu H; Yang M; Lu Y; Ma L; Li X; Wu H; Zheng C; Han P
    Cancer Imaging; 2024 May; 24(1):55. PubMed ID: 38725034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer detection with dual-energy CT: diagnostic performance of 40 keV and 70 keV virtual monoenergetic images.
    Noda Y; Ando T; Kaga T; Yamda N; Seko T; Ishihara T; Kawai N; Miyoshi T; Ito A; Naruse T; Hyodo F; Kato H; Kambadakone AR; Matsuo M
    Radiol Med; 2024 May; 129(5):677-686. PubMed ID: 38512626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study.
    Rigiroli F; Hoye J; Lerebours R; Lafata KJ; Li C; Meyer M; Lyu P; Ding Y; Schwartz FR; Mettu NB; Zani S; Luo S; Morgan DE; Samei E; Marin D
    Radiology; 2021 Dec; 301(3):610-622. PubMed ID: 34491129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis.
    Park S; Jang JK; Byun JH; Kim JH; Lee SS; Kim HJ; Hong SB; Park SH
    Eur Radiol; 2021 May; 31(5):3383-3393. PubMed ID: 33123793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreas CT assessment for pancreatic ductal adenocarcinoma resectability: effect of tube voltage and slice thickness on image quality and diagnostic performance.
    Lee DH; Lee SS; Lee JM; Choi JY; Lee CH; Ha HI; Kang BK; Yu MH; Chang W; Park SJ
    Cancer Imaging; 2023 Dec; 23(1):126. PubMed ID: 38111054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the different versions of NCCN guidelines for predicting margin-negative resection of pancreatic cancer in patients undergoing upfront surgery.
    Park EJ; Jang JK; Byun JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Hwang DW; Kim SC
    Abdom Radiol (NY); 2024 Aug; 49(8):2737-2745. PubMed ID: 38802630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
    Cassinotto C; Dohan A; Zogopoulos G; Chiche L; Laurent C; Sa-Cunha A; Cuggia A; Reinhold C; Gallix B
    Eur J Radiol; 2017 Oct; 95():33-38. PubMed ID: 28987689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of CT for Evaluating Circumferential Resection Margin Status in Resectable or Borderline Resectable Pancreatic Head Cancer: A Prospective Study Using Axially Sliced Surgical Pathologic Correlation.
    Park JH; Yoon YS; Lee S; Kim HY; Han HS; Lee JS; Chang W; Kim H; Na HY; Han S; Lee KH
    Korean J Radiol; 2022 Mar; 23(3):322-332. PubMed ID: 35029083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer.
    Bereska JI; Janssen BV; Nio CY; Kop MPM; Kazemier G; Busch OR; Struik F; Marquering HA; Stoker J; Besselink MG; Verpalen IM;
    Eur Radiol Exp; 2024 Feb; 8(1):18. PubMed ID: 38342782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria.
    Hong SB; Lee SS; Kim JH; Kim HJ; Byun JH; Hong SM; Song KB; Kim SC
    Radiology; 2018 Dec; 289(3):710-718. PubMed ID: 30251929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual monoenergetic reconstructions of dynamic DECT acquisitions for calculation of perfusion maps of blood flow: Quantitative comparison to conventional, dynamic 80 kV
    Skornitzke S; Kauczor HU; Stiller W
    Eur J Radiol; 2020 Oct; 131():109262. PubMed ID: 32942200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal conspicuity of pancreatic ductal adenocarcinoma in virtual monochromatic imaging reconstructions on a photon-counting detector CT: comparison to conventional MDCT.
    Decker JA; Becker J; Härting M; Jehs B; Risch F; Canalini L; Wollny C; Scheurig-Muenkler C; Kroencke T; Schwarz F; Bette S
    Abdom Radiol (NY); 2024 Jan; 49(1):103-116. PubMed ID: 37796327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.